DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORS

Author's Avatar
Jan 06, 2022

Former CEO/Director Dr. Morris C. Laster Believes Election of New Directors to Scopus's Board Will Help Ensure Effective, Independent Oversight of Company's Affairs

PR Newswire